Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions

Healthy Volunteers

Interventions

DRUG

Abacavir/Lamivudine

Abacavir/Lamivudine 600/300 mg QD for 5 days

DRUG

Abacavir/Lamivudine

Abacavir/Lamivudine 600/300 mg QD for 10 days

DRUG

Lersivirine

Lersivirine 750 mg QD for 10 days

Trial Locations (1)

Pfizer Investigational Site, New Haven